IAPP and type 2 diabetes mellitus: Discovering the feature changes of amyloidosis proteins during cross-interaction of Aβ40 and amylin considering all possible effective parameters such as tautomerism would be determined to design drugs that could help prevent toxic cross-seeding of amyloid peptides and developing AD in those with type 2 diabetes.